The
Vol. 1.1
06.29.2026
Medically Reviewed by Candace Westgate, DO
Updated June 29, 2026
Quick Answers
Perimenopause and menopause affect way more than your mood and your sleep. Up to 87% of women experience real, disruptive changes below the belt — dryness, burning, pain with sex, urinary leakage — and most never hear that these symptoms have a name (GSM) or that effective treatment exists.
This article breaks down how hormones support vaginal and pelvic health, what your options actually are (including hormone therapy, vaginal estrogen, and clean non-hormonal alternatives), and how to find a provider who takes you seriously.
Perimenopause and menopause don’t just mean hot flashes and night sweats. Up to 87% of women experience disruptive symptoms below the belt: vaginal dryness, burning, itching, pain with sex (dyspareunia), micro-tears, and urinary incontinence or recurrent infections. Collectively, these changes are part of Genitourinary Syndrome of Menopause (GSM), a condition caused by declining hormones that normally keep your vaginal and urinary tissue healthy, cushioned, and well lubricated.
Hormones — especially estrogen — play a major role in keeping the pelvic tissues healthy. Estrogen helps maintain natural lubrication, elasticity, and thickness in the tissues of the vulva, vagina, urethra, and perianal area. It also supports blood flow, collagen production, and a balanced vaginal microbiome, all of which are essential for comfort and sexual health.
During perimenopause and menopause, estrogen levels decline. As a result, the skin and tissues in these areas can become thinner, less elastic, and less naturally lubricated.
The loss of estrogen also shifts the vaginal microbiome: protective Lactobacillus bacteria decrease, vaginal pH rises (it becomes less acidic), and that makes tissue more vulnerable to irritation and infection.
This can lead to:
MHT — also called systemic hormone therapy — supplements the estrogen, progesterone, or testosterone that drop when you enter perimenopause and menopause.
Unlike vaginal estrogen that works only in the pelvic area, MHT travels through the bloodstream and supports the whole body. It is used to relieve common menopause symptoms such as:
MHT can also help support bone health, cognitive function, and overall well-being as hormones change with age.
There are several ways to take MHT, depending on your needs and preferences:
Your healthcare provider can help determine which form and dose are best for you based on your symptoms, medical history, and health goals.
For vaginal dryness, pain with sex, or urinary symptoms, local vaginal estrogen may be recommended, either alone or alongside MHT.
Vaginal estrogen works right where the tissue needs support, with minimal absorption into the bloodstream, and is available as:
Vaginal estrogen and MHT are both effective options for managing GSM.
If your main symptoms are vaginal dryness, irritation, pain with sex, or urinary urgency, vaginal estrogen is often the first-line treatment. It works locally in the vaginal and vulvar tissues, making it a targeted option for below-the-belt discomfort.
MHT may be recommended if you are also experiencing whole-body symptoms such as hot flashes, night sweats, brain fog, mood changes, or sleep disruption.
You can absolutely use both. Many women benefit from combining vaginal estrogen with MHT for comprehensive relief.
Always work with a menopause-trained clinician to determine the safest and most effective plan for your individual health history and goals.
The latest position statement from The Menopause Society, the leading U.S. medical organization on menopause care, education, and treatment guidelines, concludes that hormone therapy is the most effective treatment for hot flashes and GSM.
Like any medical therapy, MHT does come with potential risks, but for many women, especially those who start it near the menopause transition (within 10 years of their last period), the benefits often outweigh the risks. And importantly, our understanding of menopause and hormone therapy has advanced dramatically over the last 20 years, leading to safer dosing, better delivery methods, and more personalized care than before.
Today, hormone therapy is about the right treatment, for the right person, at the right time, in the right formulation, for the right duration.
Some Considerations When Exploring MHT:
Like any therapy, safety depends on the type, dose, route, timing, and personal risk factors. It is important to consult with your healthcare provider to determine the best intervention for your specific situation.
No, you cannot get true MHT over-the-counter. Hormone therapy must be prescribed and monitored by a licensed healthcare provider. This ensures the right dose, delivery method, and safety screening based on your health history.To start MHT, you’ll typically work with an OB/GYN, menopause-trained primary care provider, nurse practitioner, or another licensed provider.
Some over-the-counter supplements claim to balance hormones or relieve perimenopause and menopause symptoms. While some women find relief, these products:Do not replace hormones Vary widely in quality and evidence Are not regulated for safety Always check with your healthcare provider before starting supplements.
Some over-the-counter supplements claim to balance hormones or relieve perimenopause and menopause symptoms. While some women find relief, these products:
Always check with your healthcare provider before starting supplements.
There are effective non-hormonal strategies to help manage symptoms!
| LOOK FOR | AVOID |
|---|---|
| pH balanced (3.8-4.5) - supports healthy vaginal flora | Glycerin or propylene glycol - can sting or feed yeast |
| Gentle hydrators - hyaluronic acid, vitamin E, squalane | Parabens or phenoxyethanol - preservatives that irritate thin tissue |
| Short ingredients list - simple, transparent, free of fragrance or alcohol | Fragrance, essential oils, or “tingling” ingredients like menthol, peppermint, or cinnamon |
| The right texture for you: Water-based for everyday comfort Silicone-based for long-lasting moisture Oil-based for external soothing (not condom-safe) | Petroleum or mineral oil - traps bacteria, damages condoms |
| Products with “freshening” or “tightening” claims - disrupt vaginal and vulvar balance |
Too many women report feeling dismissed or gaslit when they bring up menopause or GSM. If your doctor minimizes your symptoms or says, “That’s just part of aging,” you have the right to seek care elsewhere. Here’s how to find a more supportive provider:
You don’t have to just live with below the belt discomfort during perimenopause and menopause. Work with a clinician who listens, considers your personal history and risk, and offers a stepwise plan that includes clean, supportive topicals, pelvic floor care, and, when appropriate, hormone therapy.
Mili N, Paschou SA, Armeni A, Georgopoulos N, Goulis DG, Lambrinoudaki I. Genitourinary syndrome of menopause: a systematic review on prevalence and treatment. Menopause. 2021 Mar 15;28(6):706-716. doi: 10.1097/GME.0000000000001752. PMID: 33739315.
Farrell E. Genitourinary syndrome of menopause. Australian Family Physician. 2017;46(7):481–484. Royal Australian College of General Practitioners. https://www.racgp.org.au/getattachment/eb61dedb-9431-4092-9015-8818d6364889/Genitourinary-syndrome-of-menopause.aspx
Faubion, Stephanie S. MD, MBA, FACP, NCMP; Crandall, Carolyn J. MD, MS, MACP, NCMP, FASBMR; Davis, Lori DNP, FNP-C, NCMP; El Khoudary, Samar R. PhD, MPH, FAHA; Hodis, Howard N. MD; Lobo, Roger A. MD; Maki, Pauline M. PhD; Manson, JoAnn E. MD, DrPH, MACP, NCMP; Pinkerton, JoAnn V. MD, FACOG, NCMP; Santoro, Nanette F. MD; Shifren, Jan L. MD, NCMP; Shufelt, Chrisandra L. MD, MS, FACP, NCMP; Thurston, Rebecca C. PhD, FABMR, FAPS; Wolfman, Wendy MD, FRCSC, FACOG. The 2022 hormone therapy position statement of The North American Menopause Society. Menopause 29(7):p 767-794, July 2022. | DOI: 10.1097/GME.0000000000002028
Santen RJ, Mirkin S, Bernick B, Constantine GD. Systemic estradiol levels with low-dose vaginal estrogens. Menopause. 2020 Mar;27(3):361-370. doi: 10.1097/GME.0000000000001463. PMID: 31794498; PMCID: PMC7050796.
Danan ER, Sowerby C, Ullman KE, Ensrud K, Forte ML, Zerzan N, Anthony M, Kalinowski C, Abdi HI, Friedman JK, Landsteiner A, Greer N, Nardos R, Fok C, Dahm P, Butler M, Wilt TJ, Diem S. Hormonal Treatments and Vaginal Moisturizers for Genitourinary Syndrome of Menopause : A Systematic Review. Ann Intern Med. 2024 Oct;177(10):1400-1414. doi: 10.7326/ANNALS-24-00610. Epub 2024 Sep 10. PMID: 39250810; PMCID: PMC12333043.